Olynth Plus nasal spray

Olynth is a well-known brand of nasal decongestants originally developed in Germany. It was part of the Pfizer consumer healthcare portfolio before being acquired by Johnson & Johnson. In 2023, Johnson & Johnson spun off its consumer health division into a new independent company called Kenvue. Consequently, Olynth is now owned and managed by Kenvue.

While the brand has its roots in German pharmaceutical innovation, manufacturing occurs in various international locations to serve different European markets. The product shown in the image, Olynth Plus, typically contains xylometazoline and dexpanthenol and is widely distributed across Central and Eastern Europe through local subsidiaries such as Johnson & Johnson GmbH or Kenvue's regional entities.